Comparison of Two Techniques of Sciatic Nerve Block With Levobupivacaine 0.5% in Orthopedic Surgery

Sponsor
CES University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01734954
Collaborator
Hospital Pablo Tobón Uribe (Other), Clínica CES (Other)
66
2
2
5
33
6.6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the latency period (timing between the injection of the local anesthetic and the onset of complete sensory nerve block) of two approaches for ultrasound-guided popliteal sciatic nerve block: One of the approaches is the injection of the anesthetic just at the site of the bifurcation of the sciatic nerve and the other one is injecting the local anesthetic at least 2 cm beyond the bifurcation of the aforementioned nerve. Our main hypothesis is that the first approach will decrease the latency period, and probably, will increase the success rate of the nerve block as well as patient satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Sciatic nerve anesthesia blockade at bifurcation.
  • Procedure: Sciatic nerve blockade 2 cm beyond the bifurcation
  • Drug: Levobupivacaine 0.5%: 20 ml
  • Device: Portable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WA
  • Device: Insulated Needle, (Stimuplex; Braun, Melsungen, Germany)
  • Drug: supplemental oxygen
  • Drug: Midazolam
  • Drug: Intravenous analgesics
  • Procedure: Saphenous nerve block
N/A

Detailed Description

Compare the effectiveness of nerve blockade at the bifurcation site of the sciatic nerve versus distal (tibial and peroneal) using only levobupivacaine 0.5%. The primary outcome is the latency period of the nerve blockade; the secondary outcomes are rate of success of the procedure as well as patient satisfaction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Two Techniques of Ultrasound-guided Sciatic Nerve Block Using Levobupivacaine 0.5% in Orthopedic Surgery at the Hospital Pablo Tobon Uribe - Clínica CES, 2013, Randomized Clinical Trial
Study Start Date :
Apr 1, 2013
Anticipated Primary Completion Date :
Aug 1, 2013
Anticipated Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sciatic nerve blockade at bifurcation

Ultrasound-guided block at the bifurcation of the sciatic nerve

Procedure: Sciatic nerve anesthesia blockade at bifurcation.
A proximal and distal initial scan and define the site to block the bifurcation. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% and a total volume of 20 mL.
Other Names:
  • Sciatic Nerve Block
  • Drug: Levobupivacaine 0.5%: 20 ml
    Levobupivacaine is a local anesthetic that is commonly use for anesthesia nerve blockade.
    Other Names:
  • Local Anesthetic
  • Device: Portable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WA
    An ultrasound machine is a device that is widely used for the correct placement of the local anesthetic for anesthesia nerve blockade.
    Other Names:
  • Ultrasound
  • Device: Insulated Needle, (Stimuplex; Braun, Melsungen, Germany)
    This is a specific kind of needle that is widely used for anesthesia nerve blockade.
    Other Names:
  • Nerve blockade needle short bevel.
  • Drug: supplemental oxygen
    supplemental oxygen during the block and/or during surgery
    Other Names:
  • oxygen
  • Drug: Midazolam
    Intravenous midazolam for sedation during the block and/or during surgery

    Drug: Intravenous analgesics
    Intraoperative administration intravenous of dipyrone 30-50 mg/Kg and or intravenous ketoprofen 100 mg or diclofenac 75 mg or ketorolac 30 mg

    Procedure: Saphenous nerve block
    Depending on sensitive territory committed by the type of surgery suprapatellar saphenous nerve block guided by ultrasound with 100 mm Stimuplex needle and injection of levobupivacaine 0.5% (total volume: 5 ml).

    Experimental: Sciatic block 2 cm beyond bifurcation

    Ultrasound-guided block of the sciatic nerve 2 cm beyond of the bifurcation

    Procedure: Sciatic nerve blockade 2 cm beyond the bifurcation
    A proximal and distal initial scan and define the sites to block: tibial and peroneal nerves separate distal 2 cm from the bifurcation site. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% 10 mL tibial nerve and 10 mL to the peroneal nerve.
    Other Names:
  • Sciatic nerve block
  • Drug: Levobupivacaine 0.5%: 20 ml
    Levobupivacaine is a local anesthetic that is commonly use for anesthesia nerve blockade.
    Other Names:
  • Local Anesthetic
  • Device: Portable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WA
    An ultrasound machine is a device that is widely used for the correct placement of the local anesthetic for anesthesia nerve blockade.
    Other Names:
  • Ultrasound
  • Device: Insulated Needle, (Stimuplex; Braun, Melsungen, Germany)
    This is a specific kind of needle that is widely used for anesthesia nerve blockade.
    Other Names:
  • Nerve blockade needle short bevel.
  • Drug: supplemental oxygen
    supplemental oxygen during the block and/or during surgery
    Other Names:
  • oxygen
  • Drug: Midazolam
    Intravenous midazolam for sedation during the block and/or during surgery

    Drug: Intravenous analgesics
    Intraoperative administration intravenous of dipyrone 30-50 mg/Kg and or intravenous ketoprofen 100 mg or diclofenac 75 mg or ketorolac 30 mg

    Procedure: Saphenous nerve block
    Depending on sensitive territory committed by the type of surgery suprapatellar saphenous nerve block guided by ultrasound with 100 mm Stimuplex needle and injection of levobupivacaine 0.5% (total volume: 5 ml).

    Outcome Measures

    Primary Outcome Measures

    1. Latency period of sciatic nerve block. [5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes and 30 minutes after nerve block.]

      Once the nerve blockade is done, a sensory evaluation will be performed in the surgical area every five minutes to determine the onset of the sensory nerve blockade in minutes.

    Secondary Outcome Measures

    1. Success of sciatic nerve block [Every 5 minutes until 30 minutes until the end of the procedure for the nerve block; an additional measure will be performed at the end of of the surgery.]

      The time to achieve a complete sensory nerve block, reached maximum at 30 minutes, in full distribution of tibial nerve and common fibular nerve for anesthesia.

    2. Patient satisfaction [Postoperative 24 hours]

      Using a categorical score we will measure satisfaction of nerve-block-procedure satisfaction and analgesia quality one day after surgery: patients will choose one of three options: no satisfied, satisfied or very satisfied.

    3. Sensory block [5, 10, 15, 20, 25 and 30 minutes after the block is finished]

      Evaluation in 5, 10, 15, 20, 25 and 30 minutes after the procedure in the distribution of the common peroneal and tibial nerves 0: Complete sensory block Almost complete sensory block: Decreased sensation to pinprick with a 24 gauge hypodermic needle Feeling normal (for each component: tibial and common peroneal) compared with the contralateral leg

    4. Motor block [5, 10, 15, 20, 25 and 30 minutes of completion after the block is finished]

      Evaluation in 5, 10, 15, 20, 25 and 30 minutes after the procedure in the distribution of the common peroneal and tibial nerves 0: Complete motor blockade Motor block almost complete No motor block (for the tibial component for plantarflexion and dorsiflexion with the common peroneal) compared with the contralateral leg

    5. First analgesic [5 minutes, 30 minutes, 24 hours postoperative]

      Time of first analgesic requirement in postoperative

    6. Visual analog scale at rest [5 minutes, 30 minutes, 24 hours postoperative]

      Pain rating ranging from zero to ten VAS 0: no pain VAS 1-3: Mild pain VAS 4-6: Moderate Pain VAS 7-10: Severe pain

    7. Dynamic visual analog scale [5 minutes, 30 minutes, 24 hours postoperative]

      Pain rating ranging from zero to ten with the movement

    8. Intraneural injection [At the time of injection and execution of the block]

      Increased diameter nerve or visualized by ultrasound visualization of the needle into the nerve at the time of injection

    9. Vascular puncture [During the execution of the block]

      Puncture of one or more blood vessels to visualize the needle within the vessel or to aspirate blood during block

    10. Paresthesia during the procedure [At the time of the execution of the block]

      Paresthesia during the procedure

    11. Systemic toxicity of local anesthetics [During the execution of the block and 30 minutes after it]

      Systemic toxicity of local anesthetics

    12. Hematoma [During and inmmediately after the execution of the block]

      Hematoma

    13. Muscle weakness [24 hours postoperative]

      Subjective reduction in muscle strength at 24 hours postoperative

    14. Altered sensitivity [24 hours postoperative]

      Subjective decreased sensitivity at 24 hours postoperative

    15. Cramps postoperative [24 hours postoperative of the block]

      Feeling cramps within 24 hours of the block

    16. Punctures [During the block]

      Number of skin punctures during the block

    17. Time for the execution of nerve block [In minutes: Time from placement of the transducer for the initial scan to final withdrawal of the needle]

      Time from placement of the transducer for the initial scan to final withdrawal of the needle

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients scheduled for ankle or foot surgery at Hospital Pablo Tobón Uribe and Clínica CES.

    • Physical status classification of the American Society of Anesthesiologists (ASA) 1-3.

    • Age: 18-70 years.

    • Weight: 40-100 kg

    • Taller than 140 cm.

    Exclusion Criteria:
    • No patient acceptance.

    • Contraindications for nerve block (coagulopathy, local anesthetics allergy, sepsis, infection at the site of puncture).

    • Neuropathy or myopathy affecting the lower limb.

    • Psychiatric or neurological diseases that alter the evaluation of patient.

    • Arrhythmias.

    • Heart failure.

    • Diabetes Mellitus.

    • Pregnancy.

    • Language barriers.

    • Anticoagulation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Pablo Tobón Uribe Medellín Antioquia Colombia 050034
    2 Clínica CES Medellín Antioquia Colombia

    Sponsors and Collaborators

    • CES University
    • Hospital Pablo Tobón Uribe
    • Clínica CES

    Investigators

    • Principal Investigator: Marta I Berrio, MD, CES University, Medellín, Antioquia, Colombia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marta Inés Berrío Valencia, Anesthesiologist, CES University
    ClinicalTrials.gov Identifier:
    NCT01734954
    Other Study ID Numbers:
    • IACES
    First Posted:
    Nov 28, 2012
    Last Update Posted:
    Apr 19, 2013
    Last Verified:
    Apr 1, 2013

    Study Results

    No Results Posted as of Apr 19, 2013